Protofibril Formation of Amyloid β-Protein at Low pH via a Non-cooperative Elongation Mechanism*

Deposition of the amyloid β-protein (Aβ) in senile or diffuse plaques is a distinctive feature of Alzheimer's disease. The role of Aβ aggregates in the etiology of the disease is still controversial. The formation of linear aggregates, known as amyloid fibrils, has been proposed as the onset and the cause of pathological deposition. Yet, recent findings suggest that a more crucial role is played by prefibrillar oligomeric assemblies of Aβ that are highly toxic in the extracellular environment. In the present work, the mechanism of protofibril formation is studied at pH 3.1, starting from a solution of oligomeric precursors. By combining static light scattering and photon correlation spectroscopy, the growth of the mass and the size of aggregates are determined at different temperatures. Analysis and scaling of kinetic data reveal that under the studied conditions protofibrils are formed via a single non-cooperative elongation mechanism, not prompted by nucleation. This process is well described as a linear colloidal aggregation due to diffusion and coalescence of growing aggregates. The rate of elongation follows an Arrhenius law with an activation enthalpy of 15 kcal mol–1. Such a value points to a conformational change of peptides or oligomers being involved in binding to protofibrils or in general to a local reorganization of each aggregate. These results contribute to establishing a clearer relation at the molecular level between the fibrillation mechanism and fibrillar precursors. The observation of a non-cooperative aggregation pathway supports the hypothesis that amyloid formation may represent an escape route from a dangerous condition, induced by the presence of toxic oligomeric species.

[1]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[2]  C. Yip,et al.  Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption. , 2001, Biophysical journal.

[3]  D. Walsh,et al.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. , 1997, The Journal of biological chemistry.

[4]  J. Kelly,et al.  Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.

[5]  A. Westlind-Danielsson,et al.  Spontaneous in vitro formation of supramolecular beta-amyloid structures, "betaamy balls", by beta-amyloid 1-40 peptide. , 2001, Biochemistry.

[6]  L. Regan,et al.  A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy. , 2003, Biophysical journal.

[7]  Harvey Gould,et al.  Kinetics of Aggregation and Gelation , 1985 .

[8]  Regina M. Murphy,et al.  Probing the Kinetics of β-Amyloid Self-Association , 2000 .

[9]  D. Teplow,et al.  Kinetic Studies of Amyloid β-Protein Fibril Assembly , 2002, The Journal of Biological Chemistry.

[10]  R. Murphy,et al.  A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. , 2001, Biophysical journal.

[11]  P. Lansbury,et al.  Abeta protofibrils possess a stable core structure resistant to hydrogen exchange. , 2003, Biochemistry.

[12]  D. Small,et al.  Beta-amyloid protein oligomers induced by metal ions and acid pH are distinct from those generated by slow spontaneous ageing at neutral pH. , 2003, European journal of biochemistry.

[13]  D. Selkoe Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[14]  D. Selkoe,et al.  Deciphering the genetic basis of Alzheimer's disease. , 2002, Annual review of genomics and human genetics.

[15]  Kazuki Sato,et al.  Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. L. Hill Length dependence of rate constants for end-to-end association and dissociation of equilibrium linear aggregates. , 1983, Biophysical journal.

[17]  Weitz,et al.  Dynamic scaling of cluster-mass distributions in kinetic colloid aggregation. , 1986, Physical review letters.

[18]  R. Pecora Dynamic Light Scattering , 1985 .

[19]  M. Bolognesi,et al.  Monitoring the process of HypF fibrillization and liposome permeabilization by protofibrils. , 2004, Journal of molecular biology.

[20]  P. Fraser,et al.  Alternate aggregation pathways of the Alzheimer beta-amyloid peptide. An in vitro model of preamyloid. , 2000, The Journal of biological chemistry.

[21]  B. Bevis,et al.  The assembly of amyloidogenic yeast sup35 as assessed by scanning (atomic) force microscopy: an analogy to linear colloidal aggregation? , 2001, Biophysical journal.

[22]  M. Emmerling,et al.  Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.

[23]  M. Davies,et al.  Morphological Development of β(1-40) Amyloid Fibrils , 1999, Experimental Neurology.

[24]  V. Martorana,et al.  Effects of intermediates on aggregation of native bovine serum albumin. , 2001, Biophysical chemistry.

[25]  H. Yamakawa,et al.  Translational Friction Coefficient of Wormlike Chains , 1973 .

[26]  P. Fraser,et al.  Alternate Aggregation Pathways of the Alzheimer β-Amyloid Peptide: Aβ Association Kinetics at Endosomal pH , 2003 .

[27]  M. Ball,et al.  Water-soluble A(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains (*) , 1996, The Journal of Biological Chemistry.

[28]  M. Kirkitadze,et al.  Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. , 2001, Journal of molecular biology.

[29]  R. Carrotta,et al.  Conformational characterization of oligomeric intermediates and aggregates in β‐lactoglobulin heat aggregation , 2001, Protein science : a publication of the Protein Society.

[30]  P. Lansbury,et al.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.

[31]  M. Kirkitadze,et al.  Structure determination of micelle-like intermediates in amyloid β-protein fibril assembly by using small angle neutron scattering , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Dobson,et al.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution , 2003, Journal of Molecular Medicine.

[33]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Fereydoon Family,et al.  PERSPECTIVES IN THE KINETICS OF AGGREGATION AND GELATION , 1984 .

[35]  G. Krafft,et al.  In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis* , 2003, The Journal of Biological Chemistry.

[36]  J. McLaurin,et al.  Membrane Disruption by Alzheimer β-Amyloid Peptides Mediated through Specific Binding to Either Phospholipids or Gangliosides , 1996, The Journal of Biological Chemistry.

[37]  G. Damaschun,et al.  Assembly of amyloid protofibrils via critical oligomers--a novel pathway of amyloid formation. , 2003, Journal of molecular biology.

[38]  A. D'Ursi,et al.  Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain. , 2002, European journal of biochemistry.

[39]  P. Gennes Scaling Concepts in Polymer Physics , 1979 .

[40]  R. Bauer,et al.  Characterization and isolation of intermediates in beta-lactoglobulin heat aggregation at high pH. , 2000, Biophysical journal.

[41]  P. Lansbury Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[43]  D. Kirschner,et al.  On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Transitional aggregation kinetics in dry and damp environments. , 1995, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics.

[45]  Fumio Oosawa,et al.  Thermodynamics of the polymerization of protein , 1975 .

[46]  Sarah Tomlin,et al.  Microtechnology: Laying it on thick , 1999, Nature.

[47]  George B. Benedek,et al.  Temperature dependence of amyloid β-protein fibrillization , 1998 .

[48]  S. Fujime,et al.  [Dynamic light-scattering]. , 1985, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[49]  S. Chandrasekhar Stochastic problems in Physics and Astronomy , 1943 .

[50]  And J. Sklansky,et al.  Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. , 2000, Biochemistry.

[51]  J. Hoh,et al.  Growth of β-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy , 2002 .

[52]  Ernst,et al.  Dynamic scaling in the kinetics of clustering. , 1985, Physical review letters.

[53]  Regina M. Murphy,et al.  Kinetics of aggregation of synthetic β-amyloid peptide , 1992 .

[54]  José García de la Torre,et al.  Comparison of theories for the translational and rotational diffusion coefficients of rod‐like macromolecules. Application to short DNA fragments , 1984 .

[55]  P. Fraser,et al.  Structural studies of soluble oligomers of the alzheimer β-amyloid peptide , 2000 .

[56]  G. Bitan,et al.  Amyloid (cid:1) -Protein Oligomerization PRENUCLEATION INTERACTIONS REVEALED BY PHOTO-INDUCED CROSS-LINKING OF UNMODIFIED PROTEINS* , 2001 .

[57]  P. Lansbury,et al.  Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.

[58]  H. Edelhoch,et al.  Spectroscopic determination of tryptophan and tyrosine in proteins. , 1967, Biochemistry.

[59]  J. Lahti,et al.  Use of gene knockouts in cultured cells to study apoptosis. , 1999, Methods.

[60]  M. Davies,et al.  In-situ atomic force microscopy study of beta-amyloid fibrillization. , 2000, Journal of molecular biology.

[61]  D. Selkoe,et al.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. , 1999, The Journal of biological chemistry.

[62]  M. Fitzgerald,et al.  Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide. , 1994, Biophysical journal.

[63]  W. Brown,et al.  Light Scattering: Principles and development , 1996 .

[64]  George B. Benedek,et al.  Kinetic theory of fibrillogenesis of amyloid β-protein , 1997 .

[65]  D. Weitz,et al.  Dynamics of diffusion-limited kinetic aggregation , 1984 .

[66]  D. Teplow,et al.  Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s disease , 2004, Neurobiology of Aging.

[67]  S. Leibler,et al.  Kinetics of self-assembling microtubules: an "inverse problem" in biochemistry. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Tamás Vicsek,et al.  Dynamic Scaling for Aggregation of Clusters , 1984 .

[69]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[70]  Sorensen,et al.  Variable aggregation rates in colloidal gold: Kernel homogeneity dependence on aggregant concentration. , 1990, Physical review. A, Atomic, molecular, and optical physics.

[71]  Satoshi Takahashi,et al.  Direct Observation of Aβ Amyloid Fibril Growth and Inhibition , 2004 .

[72]  Taylor,et al.  Moment analysis of the cluster-size-distribution approach to scaling during coagulation. , 1987, Physical review. A, General physics.

[73]  C M Dobson,et al.  Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[74]  M. Kirkitadze,et al.  Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies , 2002, Journal of neuroscience research.

[75]  Peter T. Lansbury,et al.  Assembly of Aβ Amyloid Protofibrils: An in Vitro Model for a Possible Early Event in Alzheimer's Disease† , 1999 .

[76]  P. Lansbury,et al.  Amyloid fibrillogenesis: themes and variations. , 2000, Current opinion in structural biology.